Skip to main content

Table 1 Sensitization characteristics (per-protocol analysis)

From: Effect of individual allergen sensitization on omalizumab treatment outcomes in patients with severe allergic asthma determined using data from the Czech Anti-IgE Registry

Sensitization

Whole sample

Responders

Non-responders

Withdrew

p

 

n

%

n

%

N

%

n

%

n

279

100.0

161

57.7

48

17.2

70

25.1

 

Monosensitization Alternaria

3

1.1

2

1.2

1

2.1

0

0.0

0.249

Monosensitization Aspergillus

12

4.3

6

3.7

1

2.1

5

7.1

Cats and dogs

22

7.9

14

8.

4

8.3

4

5.7

Molds, cats, and dogs

14

5.0

8

5.0

3

6.3

3

4.3

Molds

24

8.6

12

7.5

4

8.3

8

11.4

Mites, cats, and dogs

51

18.3

31

19.3

11

22.9

9

12.9

Mites and molds

32

11.5

14

8.7

4

8.3

14

20.0

Mites

70

25.1

37

23.0

16

33.3

17

24.3

Mites, molds, cats, and dogs

51

18.3

37

23.0

4

8.3

10

14.3

Polysensitization

51

18.3

37

23.0

4

8.3

10

14.3

0.043

Non-polysensitization

228

81.7

124

77.0

44

91.7

60

85.7

  1. Analysis: Chi squared test